nach oben

Erschienen in:

01.04.2011 | Medizin aktuell

Diabetes mellitus und Parodontitis

Wechselbeziehung und klinische Implikationen. Ein Konsensuspapier

verfasst von: J. Deschner, T. Haak, Prof. Dr. Dr. S. Jepsen, T. Kocher, H. Mehnert, J. Meyle, P.-M. Schumm-Draeger, D. Tschöpe

Erschienen in: Die Innere Medizin | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Zusammenfassung

Diabetes und Parodontitis sind weit verbreitete chronische Erkrankungen mit einer zunehmenden Prävalenz in der deutschen Bevölkerung. Zwischen beiden Erkrankungen besteht eine bidirektionale Beziehung: Der Diabetes begünstigt die Entstehung, die Progression und den Schweregrad einer Parodontitis. Die Parodontitis erschwert die glykämische Kontrolle des Diabetes, erhöht das Risiko diabetesassoziierter Komplikationen und möglicherweise sogar dessen Entstehung. Angesichts der vorliegenden Evidenz, die gerade in der Ärzteschaft noch nicht hinreichend kommuniziert worden ist, hat ein Expertengremium bestehend aus 4 Diabetologen und 4 Parodontologen im vorliegenden Konsensusreport die folgenden Fragen bearbeitet: Welchen Einfluss hat Diabetes mellitus auf Parodontitis und parodontale Therapie? Welchen Einfluss hat Parodontitis auf Diabetes mellitus? Was sind die praktischen Konsequenzen, die sich daraus für interdisziplinäre Behandlungsstrategien ableiten? Die Behandlung parodontaler Infektionen sollte integraler Bestandteil des Diabetesmanagements werden, wohingegen die Sicherstellung einer adäquaten glykämischen Einstellung wesentlicher Bestandteil einer erfolgreichen Parodontaltherapie ist.

Nur mit Berechtigung zugänglich

Alsaadi G, Quirynen M, Komárek A, Steenberghe D van (2007) Impact of local and systemic factors on the incidence of oral implant failures, up to abutment connection. J Clin Periodontol 34:610–617PubMedCrossRef

Beikler T, Flemmig TF (2003) Implants in the medically compromised patient. Crit Rev Oral Biol Med 14:305–316PubMedCrossRef

Bretz WA, Weyant RJ, Corby PM ET AL (2005) Systemic inflammatory markers, periodontal diseases, and periodontal infections in an elderly population. J Am Geriatr Soc 53:1532–1537PubMedCrossRef

Chávarry NG, Vettore MV, Sansone C, Sheiham A (2009) The relationship between diabetes mellitus and destructive periodontal disease: a meta-analysis. Oral Health Prev Dent 7:107–127PubMed

Chen L, Wei B, Li J et al (2010) Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes. J Periodontol 81:364–371PubMedCrossRef

Christgau M, Palitzsch KD, Schmalz G et al (1998) Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological, and immunological results. J Clin Periodontol 25:112–124PubMedCrossRef

Correa FO, Gonzalves D, Figueredo CM et al (2010) Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes. J Clin Periodontol 37:53–58PubMedCrossRef

Cullinan MP, Westerman B, Hamlet SM et al (2003) The effect of a triclosan-containing dentifrice on the progression of periodontal disease in an adult population. J Clin Periodontol 30;414–419

D’Aiuto F, Parkar M, Andreou G et al (2004) Periodontitis and atherogenesis: causal association or simple coincidence? J Clin Periodontol 31:402–411CrossRef

10.

Darré L, Vergnes JN, Gourdy P, Sixou M (2008) Efficacy of periodontal treatment on glycaemic control in diabetic patients: A meta-analysis of interventional studies. Diabetes Metab 34:497–506PubMedCrossRef

11.

Demmer RT, Desvarieux M, Holtfreter B et al (2010) Periodontal status and hemoglobin A1C change: longitudinal results from the study of health in pomerania (SHIP). Diabetes Care 33:1037–1043PubMedCrossRef

12.

Demmer RT, Jacobs DR Jr, Desvarieux M (2008) Periodontal disease and incident type 2 diabetes: results from the First National Health and Nutrition Examination Survey and its epidemiologic follow-up study. Diabetes Care 31:1373–1379PubMedCrossRef

13.

Ellwood RP, Worthington HV, Blinkhorn ASB et al (1998) Effect of a triclosan/copolymer dentifrice on the incidence of periodontal attachment loss in adolescents. J Clin Periodontol 25:363–367PubMedCrossRef

14.

Ferreira SD, Silva GL, Cortelli JR et al (2006) Prevalence and risk variables for peri-implant disease in Brazilian subjects. J Clin Periodontol 33(12):929–935PubMedCrossRef

15.

Gaffar A, Scherl D, Afflitto J, Coleman EJ (1995) The effect of triclosan on mediators of gingival inflammation. J Clin Periodontol 22:480–484PubMedCrossRef

16.

Geerts SO, Nys M, De MP et al (2002) Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol 73:73–78PubMedCrossRef

17.

Graves DT, Liu R, Oates TW (2007) Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathosis. Periodontol 2000 45:128–137PubMedCrossRef

18.

Gual P, Le Marchand-Brustel Y, Tanti JF (2005) Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87:99–109PubMedCrossRef

19.

Hampton T (2008) Studies probe oral health-diabetes link. JAMA 300:2471–2473PubMedCrossRef

20.

Hayashida H, Kawasaki K, Yoshimura A et al (2009) Relationship between periodontal status and HbA1c in nondiabetics. J Public Health Dent 69:204–206PubMedCrossRef

21.

Holtfreter B, Kocher T, Hoffmann T et al (2010) Prevalence of periodontal disease and treatment demands based on a German dental survey (DMS IV). J Clin Periodontol 37:211–219PubMedCrossRef

22.

Iwamoto Y, Nishimura F, Nakagawa M et al (2001) The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 72:774–778PubMedCrossRef

23.

Janket SJ, Wightman A, Baird AE et al (2005) Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res 84:1154–1159PubMedCrossRef

24.

Jansson H, Lindholm E, Lindh C et al (2006) Type 2 diabetes and risk for periodontal disease: a role for dental health awareness. J Clin Periodontol 33:408–414PubMedCrossRef

25.

Kardesler L, Buduneli N, Cetinkalp S, Kinane DF (2010) Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis. J Periodontol 81:24–33PubMedCrossRef

26.

Karjalainen KM, Knuuttila ML, Dickhoff KJ von (1994) Association of the severity of periodontal disease with organ complications in type 1 diabetic patients. J Periodontol 65:1067–1072PubMed

27.

Kaur G, Holtfreter B, Rathmann W et al (2009) Association between type 1 and type 2 diabetes with periodontal disease and tooth loss. J Clin Periodontol 36:765–774PubMedCrossRef

28.

Khader YS, Dauod AS, El-Qaderi SS et al (2006) Periodontal status of diabetics compared with nondiabetics: a meta-analysis. J Diabetes Complications 20:59–68PubMedCrossRef

29.

Kidambi S, Patel SB (2008) Diabetes mellitus: considerations for dentistry. J Am Dent Assoc 139:8p-18p

30.

Koromantzos PA, Makrilakis K, Dereka X et al (2011) A randomized, controlled trial on the effect of non-surgical periodontal therapy in patients with type 2 diabetes. Part I: effect on periodontal status and glycaemic control. J Clin Periodontol 38:142–147PubMedCrossRef

31.

Kotsovilis S, Karoussis IK, Fourmousis I (2006) A comprehensive and critical review of dental implant placement in diabetic animals and patients. Clin Oral Implants Res 17:587–599PubMedCrossRef

32.

Kressin NR, Boehmer U, Nunn ME, Spiro A (2003) Increased preventive practices lead to greater tooth retention. J Dent Res 82:223–227PubMedCrossRef

33.

Lalla E, Cheng B, Lal S et al (2007) Diabetes mellitus promotes periodontal destruction in children. J Clin Periodontol 34:294–298PubMedCrossRef

34.

Lim LP, Tay FB, Sum CF, Thai AC (2007) Relationship between markers of glycemic control and inflammation on severity of periodontal disease in patients with diabetes mellitus. J Clin Periodontol 34:118–123PubMedCrossRef

35.

Lindhe J, Meyle J (2008) Peri-implant diseases: consensus report of the sixth european workshop on periodontology. J Clin Periodontol 35(8 Suppl):282–285PubMedCrossRef

36.

Llambés F, Silvestre FJ, Hernandez-Mijares A et al (2005) Effect of non-surgical periodontal treatment with or without doxycycline on the periodontium of type 1 diabetic patients. J Clin Periodontol 32:915–920PubMedCrossRef

37.

Löe H (1993) Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care 16:329–334PubMed

38.

Loos BG, Craandijk J, Hoek FJ et al (2000) Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71:1528–1534PubMedCrossRef

39.

Mealey BL, Ocampo GL (2007) Diabetes mellitus and periodontal disease. Periodontol 2000 44:127–153PubMedCrossRef

40.

Moy PK, Medina D, Shetty V, Aghaloo TL (2005) Dental implant failure rates and associated risk factors. Int J Oral Maxillofac Implants 20:569–577PubMed

41.

Nagasawa T, Noda M, Katagiri S et al (2010) Relationship between periodontitis and diabetes – importance of a clinical study to prove the vicious cycle. Intern Med 49:881–885PubMedCrossRef

42.

Navarro-Sanchez AB, Faria-Almeida R, Bascones-Martinez A (2007) Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol 34:835–843PubMedCrossRef

43.

Nesse W, Linde A, Abbas F et al (2009) Dose-response relationship between periodontal inflamed surface area and HbA1c in type 2 diabetics. J Clin Periodontol 36:295–300PubMedCrossRef

44.

Nibali L, D’Aiuto F, Griffiths G et al (2007) Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol 34:931-937PubMedCrossRef

45.

Nishimura F, Iwamoto Y, Soga Y (2007) The periodontal host response with diabetes. Periodontol 2000 43:245–253PubMedCrossRef

46.

Oates TW, Dowell S, Robinson M, McMahan CA (2009) Glycemic control and implant stabilization in type 2 diabetes mellitus. J Dent Res 88:367–371PubMedCrossRef

47.

O’Connell PA, Taba M, Nomizo A et al (2008) Effects of periodontal therapy on glycemic control and inflammatory markers. J Clin Periodontol 79:744–783

48.

Paraskevas S, Huizinga JD, Loos BG (2008) A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 35:277–290PubMedCrossRef

49.

Perrino MA (2007) Diabetes and periodontal disease: an example of an oral/systemic relationship. NY State Dent J 73:38–41

50.

Pickup JC (2004) Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813–823PubMedCrossRef

51.

Pihlstrom BI, Michalowicz BS, Johnson NW (2005) Periodontal disease. Lancet 366:1809–1820PubMedCrossRef

52.

Pischon N, Heng N, Bernimoulin JP et al (2007) Obesity, inflammation, and periodontal disease. J Dent Res 86:400–409PubMedCrossRef

53.

Preiss DS, Meyle J (1994) Interleukin-1 beta concentration of gingival crevicular fluid. J Periodontol 65: 423–428PubMed

54.

Preshaw PM, Foster N, Taylor JJ (2007) Cross-susceptibility between periodontal disease and type 2 diabetes mellitus: an immunobiological perspective. Periodontol 2000 45:138–157PubMedCrossRef

55.

Rees TD (2000) Periodontal management of the patient with diabetes mellitus. Periodontol 2000 23:63–72PubMedCrossRef

56.

Rosling B, Wannfors B, Volpe AR et al (1997) The use of a triclosan/copolymer dentifrice may retard the progression of periodontitis. J Clin Periodontol 24:873–880PubMedCrossRef

57.

Saito T, Murakami M, Shimazaki Y et al (2006) The extent of alveolar bone loss is associated with impaired glucose tolerance in Japanese men. J Periodontol 77:392–397PubMedCrossRef

58.

Saito T, Shimazaki Y, Kiyohara Y et al (2004) The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. J Dent Res 83:485–490PubMedCrossRef

59.

Salvi GE, Carollo-Bittel B, Lang NP (2008) Effects of diabetes mellitus on periodontal and peri- implant conditions: update on associations and risks. J Clin Periodontol 35 (Suppl):398–409PubMedCrossRef

60.

Santacroce L, Carlaio RG, Bottalico L (2010) Does it make sense that diabetes is reciprocally associated with periodontal disease? Endocr Metab Immune Disord Drug Targets 10:57–70PubMed

61.

Saremi A, Nelson RG, Tulloch-Reid M et al (2005) Periodontal disease and mortality in type 2 diabetes. Diabetes Care 28:27–32PubMedCrossRef

62.

Shultis WA, Weil EJ, Looker HC et al (2007) Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 30:306–311PubMedCrossRef

63.

Simpson TC, Needleman I, Wild SH et al (2010) Treatment of periodontal disease for glycaemic control in people with diabetes. Cochrane Database Syst Rev 5:CD004714PubMed

64.

Singh S, Kumar V, Kumar S, Subbappa A (2008) The effect of periodontal therapy on the improvement of glycemic control in patients with type 2 diabetes mellitus: a randomized controlled clinical trial. Int J Diabetes Dev Ctries 28:38–44PubMedCrossRef

65.

Skamagas M, Breen TL, LeRoith D (2008) Update on diabetes mellitus: prevention, treatment, and association with oral diseases. Oral Dis 14:105–114PubMedCrossRef

66.

Staehle HJ, Schiffner U, Dörfer CE (2007) Häusliche mechanische Zahn- und Mundpflege. Dtsch Zahnärztl Z 62:616–620

67.

Strauss SM, Russell S, Wheeler A et al (2010) The dental office visit as a potential opportunity for diabetes screening: an analysis using NHANES 2003–2004 data. J Public Health Dent 70:156–162PubMed

68.

Taylor GW, Burt BA, Becker MP et al (1996) Severe periodontitis and risk for poor glycemic control in patients with non-insulin dependent diabetes mellitus. J Periodontol 67:1085–1093PubMed

69.

Taylor GW, Burt BA, Becker MP et al (1998) Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol 69:76–83PubMed

70.

Teeuw WJ, Gerdes VE, Loos BG (2010) Effect of periodontal treatment on glycemic control of diabetic patients: a systematic review and meta-analysis. Diabetes Care 33:421–427PubMedCrossRef

71.

Thorstensson H, Kuylenstierna J, Hugoson A (1996) Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol 23:194–202PubMedCrossRef

72.

Tsai C, Hayes C, Taylor GW (2002) Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 30:182–192PubMedCrossRef

73.

Vergnes JN, Arrive E, Gourdy P et al (2009) Periodontal treatment to improve glycaemic control in diabetes patients: study protocol of the randomized, controlled DIAPERIO trial. Trials 10:65PubMedCrossRef

74.

Westfelt E, Rylander H, Blohmé G et al (1996) The effects of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol 23:92–100PubMedCrossRef

75.

Wolff RE, Wolff LF, Michalowicz BS (2009) A pilot study of glycosylated hemoglobin levels in periodontitis cases and healthy controls. J Periodontol 80:1057–1061PubMedCrossRef

76.

Xiong X, Elkind-Hirsch KE, Vastardis S et al (2009) Periodontal disease is associated with gestational diabetes mellitus: a case-control study. J Periodontol 80:1742–1749PubMedCrossRef

77.

Youngren JF (2007) Regulation of insulin receptor function. Cell Mol Life Sci 64:873–891PubMedCrossRef

78.

Zahnmed up2date (2011) 5:183-201

Titel: Diabetes mellitus und Parodontitis
Wechselbeziehung und klinische Implikationen. Ein Konsensuspapier
verfasst von: J. Deschner
T. Haak
Prof. Dr. Dr. S. Jepsen
T. Kocher
H. Mehnert
J. Meyle
P.-M. Schumm-Draeger
D. Tschöpe
Publikationsdatum: 01.04.2011
Verlag: Springer-Verlag
Erschienen in: Die Innere Medizin / Ausgabe 4/2011
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI: https://doi.org/10.1007/s00108-011-2835-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Diabetes mellitus und Parodontitis

Wechselbeziehung und klinische Implikationen. Ein Konsensuspapier

Zusammenfassung

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

Update Innere Medizin

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

Pulmonalarterielle Hypertonie

Nichtalkoholische Steatohepatitis

Erratum zu:

Lipodystrophie

45-jährige Patientin mit Muskelschwäche und Hypokaliämie

Antidiabetika

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

Update Innere Medizin